Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria-Reference-Cited by-同舟云学术

Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria

Published:2016-12-28 Issue:8 Volume:91 Page:2921-2938
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Zhang Jun,Salminen Alec,Yang Xi,Luo Yong,Wu Qiangen,White Matthew,Greenhaw James,Ren Lijun,Bryant Matthew,Salminen William,Papoian Thomas,Mattes William,Shi Qiang

Funder

Office of Women’s Health

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

http://link.springer.com/article/10.1007/s00204-016-1918-1/fulltext.html

Reference24 articles.

1. Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y (2014) Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology 60(3):1015–1022. doi: 10.1002/hep.27206

2. Bull VH, Rajalingam K, Thiede B (2012) Sorafenib-induced mitochondrial complex I inactivation and cell death in human neuroblastoma cells. J Proteome Res 11(3):1609–1620. doi: 10.1021/pr200790e

3. Buron N, Porceddu M, Brabant M et al (2010) Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization. PLoS ONE 5(3):e9924. doi: 10.1371/journal.pone.0009924

4. Castellino S, O’Mara M, Koch K, Borts DJ, Bowers GD, MacLauchlin C (2012) Human metabolism of lapatinib, a dual kinase inhibitor: implications for hepatotoxicity. Drug Metab Dispos 40(1):139–150. doi: 10.1124/dmd.111.040949

5. Feng B, Xu JJ, Bi YA et al (2009) Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714. Toxicol Sci 108(2):492–500. doi: 10.1093/toxsci/kfp033

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Underlying mechanisms and management strategies for regorafenib-induced toxicity in hepatocellular carcinoma;Expert Opinion on Drug Metabolism & Toxicology;2024-09-03

2. Liraglutide alleviated alpha-pyrrolidinovalerophenone (α-PVP) induced cognitive deficits in rats by modifying brain mitochondrial impairment;European Journal of Pharmacology;2024-09

3. Higher risk of hepatotoxicity associated with cabozantinib in cancer patients;Critical Reviews in Oncology/Hematology;2024-04

4. Prediction for oxaliplatin‐induced liver injury using patient‐derived liver organoids;Cancer Medicine;2024-02

5. Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis;British Journal of Cancer;2023-08-24